Original language | English |
---|---|
Pages (from-to) | E133-E152 |
Journal | Stroke |
Volume | 52 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2021 |
Bibliographical note
Funding Information:Dr Panagos reports research grant support from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS; significant). Dr Dickson reports Speakers’ Bureau/Honoraria from Stryker Neurovascular (modest); ownership interest at Pulsara (significant); and consultant/advisory board at Pulsara (modest). Dr Fraser reports research grant support from the University of Kentucky (modest) and the American Heart Association (AHA; modest); ownership interest at Fawkes Biotechnology (modest) and Cerelux, LLC (modest); and consultant/advisory board: Stream Biomedical (modest), Medtronic (modest), and Penumbra (modest). Dr Prabhakaran reports research grant support from the Agency for Healthcare Research and Quality (AHRQ; significant) and NIH (significant); consultant/advisory board at AbbVie; and other from UpTo-Date. Dr Richards reports research grant support from AHRQ (modest) and other from the American College of Emergency Medicine (modest), AHA (modest), and Illinois EMT Association (modest). Dr Schwamm reports research grant support from Genentech (modest), Diffusion Pharma (modest), Medtronic (modest), and NINDS (significant) and Consultant/Advisory Board at Genentech (modest), LifeImage (significant), Medtronic (significant), Massachusetts Department of Public Health (significant), and Penumbra (modest).
Funding
Dr Panagos reports research grant support from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS; significant). Dr Dickson reports Speakers’ Bureau/Honoraria from Stryker Neurovascular (modest); ownership interest at Pulsara (significant); and consultant/advisory board at Pulsara (modest). Dr Fraser reports research grant support from the University of Kentucky (modest) and the American Heart Association (AHA; modest); ownership interest at Fawkes Biotechnology (modest) and Cerelux, LLC (modest); and consultant/advisory board: Stream Biomedical (modest), Medtronic (modest), and Penumbra (modest). Dr Prabhakaran reports research grant support from the Agency for Healthcare Research and Quality (AHRQ; significant) and NIH (significant); consultant/advisory board at AbbVie; and other from UpTo-Date. Dr Richards reports research grant support from AHRQ (modest) and other from the American College of Emergency Medicine (modest), AHA (modest), and Illinois EMT Association (modest). Dr Schwamm reports research grant support from Genentech (modest), Diffusion Pharma (modest), Medtronic (modest), and NINDS (significant) and Consultant/Advisory Board at Genentech (modest), LifeImage (significant), Medtronic (significant), Massachusetts Department of Public Health (significant), and Penumbra (modest).
Funders | Funder number |
---|---|
American College of Emergency Medicine | |
Massachusetts Department for Public Health | |
UpTo-Date | |
National Institutes of Health (NIH) | |
National Institute of Neurological Disorders and Stroke | |
Agency for Healthcare Research and Quality | |
American Heart Association | |
Medtronic | |
AbbVie | |
University of Kentucky |
Keywords
- brain ischemia
- certification
- consensus
- geography
- stents
ASJC Scopus subject areas
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
- Advanced and Specialized Nursing